دورية أكاديمية
أعرض في EDS

Recombinant antigen delivery to dendritic cells as a way to improve vaccine design.

التفاصيل البيبلوغرافية
العنوان: Recombinant antigen delivery to dendritic cells as a way to improve vaccine design.
المؤلفون: de Souza-Silva GA; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, 05508-000, Brazil., Sulczewski FB; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, 05508-000, Brazil., Boscardin SB; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, 05508-000, Brazil.; Instituto de Investigação em Imunologia (iii), Instituto Nacional de Ciência e Tecnologia, São Paulo, 05401-350, Brazil.
المصدر: Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2023 Oct; Vol. 248 (19), pp. 1616-1623. Date of Electronic Publication: 2023 Sep 25.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 100973463 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3699 (Electronic) Linking ISSN: 15353699 NLM ISO Abbreviation: Exp Biol Med (Maywood) Subsets: MEDLINE
أسماء مطبوعة: Publication: 2024- : Lausanne, Switzerland : Frontiers Media S.A.
Original Publication: Maywood, NJ : The Society, c2001-
مواضيع طبية MeSH: Vaccines*, Receptors, Cell Surface/metabolism ; Lectins, C-Type/metabolism ; Antibodies, Monoclonal ; Dendritic Cells
مستخلص: Dendritic cells are central to the development of immunity, as they are specialized in initiating antigen-specific immune responses. In this review, we briefly present the existing knowledge on dendritic cell biology and how their division in different dendritic cell subsets may impact the development of immune responses. In addition, we explore the use of chimeric monoclonal antibodies that bind to dendritic cell surface receptors, with an emphasis on the C-type lectin family of endocytic receptors, to deliver antigens directly to these cells. Promising preclinical studies have shown that it is possible to modulate the development of immune responses to different pathogens when monoclonal antibodies fused to pathogen-derived antigens are used to deliver the antigen to different subsets of dendritic cells. This approach can be used to improve the efficacy of vaccines against different pathogens.
Competing Interests: Declaration Of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References: J Immunol. 2009 Jun 15;182(12):7587-94. (PMID: 19494282)
J Immunol. 2014 Jun 15;192(12):5830-8. (PMID: 24829411)
PLoS One. 2012;7(10):e46959. (PMID: 23071675)
J Clin Invest. 2008 Apr;118(4):1427-36. (PMID: 18324335)
J Exp Med. 2004 Mar 15;199(6):815-24. (PMID: 15024047)
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2384-9. (PMID: 21262813)
J Immunol. 1998 Dec 1;161(11):6059-67. (PMID: 9834089)
J Immunol. 2011 Jan 15;186(2):1218-27. (PMID: 21149605)
Nature. 1995 May 11;375(6527):151-5. (PMID: 7753172)
J Exp Med. 2009 Jul 6;206(7):1589-602. (PMID: 19564349)
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4287-92. (PMID: 20142498)
Nat Rev Immunol. 2014 Oct;14(10):705-11. (PMID: 25190285)
Nature. 1987 May 7-13;327(6117):59-61. (PMID: 3472080)
Nat Cancer. 2020 Dec;1(12):1204-1217. (PMID: 35121932)
Mucosal Immunol. 2014 Jan;7(1):27-37. (PMID: 23757304)
PLoS One. 2013 Jun 26;8(6):e67453. (PMID: 23840706)
J Clin Invest. 2008 Jun;118(6):2098-110. (PMID: 18497879)
Annu Rev Immunol. 2002;20:621-67. (PMID: 11861614)
Annu Rev Immunol. 2013;31:563-604. (PMID: 23516985)
Immunity. 2009 Nov 20;31(5):823-33. (PMID: 19913446)
Science. 2007 Jan 5;315(5808):107-11. (PMID: 17204652)
Front Immunol. 2017 Dec 04;8:1727. (PMID: 29255470)
Curr Res Immunol. 2021 Aug 28;2:120-131. (PMID: 35492396)
Breast Cancer Res. 2012 Mar 07;14(2):R39. (PMID: 22397502)
J Immunol. 2008 Nov 15;181(10):6923-33. (PMID: 18981112)
Immunity. 2015 Aug 18;43(2):369-81. (PMID: 26231115)
Immunity. 2013 May 23;38(5):970-83. (PMID: 23706669)
Cell Immunol. 1989 Jan;118(1):108-25. (PMID: 2910499)
J Immunol. 2006 Dec 15;177(12):8410-21. (PMID: 17142738)
Nat Rev Immunol. 2015 Aug;15(8):471-85. (PMID: 26160613)
Sci Transl Med. 2014 Apr 16;6(232):232ra51. (PMID: 24739759)
Eur J Immunol. 2015 Feb;45(2):624-35. (PMID: 25410055)
Int J Biol Sci. 2021 Jul 13;17(11):2944-2956. (PMID: 34345218)
Eur J Immunol. 2010 May;40(5):1255-65. (PMID: 20333625)
J Exp Med. 2006 Mar 20;203(3):607-17. (PMID: 16505141)
PLoS One. 2015 Feb 13;10(2):e0117778. (PMID: 25679777)
Eur J Immunol. 2020 Dec;50(12):1895-1911. (PMID: 32673408)
Int J Cancer. 2001 Jun 15;92(6):856-60. (PMID: 11351307)
Annu Rev Immunol. 2021 Apr 26;39:759-790. (PMID: 33710920)
Vaccine. 2010 Oct 21;28(45):7256-66. (PMID: 20846528)
Int Immunopharmacol. 2001 Feb;1(2):265-75. (PMID: 11360928)
AIDS. 2006 Nov 28;20(18):2263-73. (PMID: 17117012)
Immunol Lett. 2016 Apr;172:21-8. (PMID: 26850563)
Immunology. 2010 Sep;131(1):141-51. (PMID: 20465572)
Front Immunol. 2019 Jan 29;10:59. (PMID: 30761131)
Cell Rep. 2015 Jun 30;11(12):1929-40. (PMID: 26095362)
Immunol Lett. 2017 Oct;190:118-124. (PMID: 28802641)
Clin Cancer Res. 2018 Mar 1;24(5):1019-1029. (PMID: 28947565)
Clin Transl Immunology. 2016 Mar 18;5(3):e66. (PMID: 27217957)
Front Immunol. 2016 May 02;7:168. (PMID: 27199991)
Front Immunol. 2017 Feb 07;8:101. (PMID: 28223987)
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2574-9. (PMID: 18256187)
Sci Rep. 2016 Dec 21;6:39250. (PMID: 28000705)
Blood. 2008 Oct 15;112(8):3264-73. (PMID: 18669894)
Eur J Immunol. 2010 Oct;40(10):2791-6. (PMID: 20812236)
J Immunol. 2006 Aug 15;177(4):2276-84. (PMID: 16887988)
Eur J Immunol. 2008 Aug;38(8):2263-73. (PMID: 18651710)
Cell. 2001 Aug 10;106(3):255-8. (PMID: 11509172)
Front Immunol. 2022 Oct 18;13:1006996. (PMID: 36330518)
Front Immunol. 2018 Feb 20;9:317. (PMID: 29515595)
J Immunol. 1987 Sep 1;139(5):1609-16. (PMID: 2957430)
J Exp Med. 2001 Sep 17;194(6):769-79. (PMID: 11560993)
J Exp Med. 2002 Dec 16;196(12):1627-38. (PMID: 12486105)
Immunity. 2002 Sep;17(3):235-8. (PMID: 12354377)
Immun Inflamm Dis. 2018 Mar;6(1):163-175. (PMID: 29205929)
J Exp Med. 2006 Mar 20;203(3):599-606. (PMID: 16505139)
Immunology. 2013 Sep;140(1):22-30. (PMID: 23621371)
Eur J Immunol. 2015 Mar;45(3):854-64. (PMID: 25487143)
PLoS Negl Trop Dis. 2013 Jul 18;7(7):e2330. (PMID: 23875054)
J Immunol. 2011 Jul 15;187(2):842-50. (PMID: 21677141)
فهرسة مساهمة: Keywords: B cell response; Dendritic cell; T cell response; antigen targeting; monoclonal antibody; vaccination
المشرفين على المادة: 0 (Vaccines)
0 (Receptors, Cell Surface)
0 (Lectins, C-Type)
0 (Antibodies, Monoclonal)
تواريخ الأحداث: Date Created: 20230926 Date Completed: 20231216 Latest Revision: 20240326
رمز التحديث: 20240326
مُعرف محوري في PubMed: PMC10723026
DOI: 10.1177/15353702231191185
PMID: 37750021
قاعدة البيانات: MEDLINE
الوصف
تدمد:1535-3699
DOI:10.1177/15353702231191185